FibroBiologics wins European patent for enhancing fibroblast therapeutic activity
Bitget2026/09/29 12:32- FibroBiologics won a European patent for methods that condition fibroblasts with platelet-rich plasma, targeting stronger regenerative activity.
- Claims cover use of cytokines including FGF-alpha or FGF-beta, with additional protection for angiogenesis-related applications.
- Patent also targets spinal disc regeneration, reinforcing the company’s disc degeneration clinical program.
- Grant expands a portfolio of more than 270 issued or pending patents across fibroblast-based therapies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
USD/JPY falls below 157! The yen becomes the strongest G-10 currency, with the market betting on another rate hike by the central bank next month.
On Wednesday, the yen strengthened against the US dollar, with the USD/JPY rate falling below the 157 mark, as repeated warnings from the Japanese government regarding exchange rates and end-of-quarter capital flows provided support for the yen.
The scale of the compute power agreement between Anthropic and SpaceX has been revealed, reaching up to $84.5 billions, double the previously disclosed amount.
According to Anthropic’s IPO prospectus, the company has signed a computing power leasing agreement with SpaceX valued at $84.5 billion, far surpassing the previously disclosed $45 billion in SpaceX’s IPO documents. The agreement runs until 2029, with most terms cancellable within 90 days. At the same time, Anthropic’s total spending on AI infrastructure over the next decade is expected to be at least $518 billion.
KOSPI Index in South Korea falls by 0.3%
Canadian Dollar remains subdued near two-month lows as falling oil prices weigh
Crypto prices
More
